Regeneron Pharmaceuticals, Inc.

Tredje AP-fonden REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

16,330

Value ($000)

12,605

Weight

0.1%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	12,605	0.1%	16,330	12/31/2025
2024 Q4	2/10/2025	19,233	0.2%	27,000	12/31/2024
2024 Q3	11/8/2024	28,383	0.3%	27,000	9/30/2024
2024 Q2	8/12/2024	28,378	0.3%	27,000	6/30/2024
2024 Q1	5/13/2024	25,987	0.3%	27,000	3/31/2024
2023 Q4	2/12/2024	4,074	0.1%	4,638	12/31/2023
2023 Q3	11/9/2023	39,590	0.6%	48,107	9/30/2023
2023 Q2	8/11/2023	35,086	0.5%	48,829	6/30/2023
2023 Q1	5/10/2023	40,024	0.6%	48,710	3/31/2023
2022 Q4	2/10/2023	20,093	0.3%	27,849	12/31/2022
2022 Q3	11/10/2022	18,080	0.4%	26,246	9/30/2022
2022 Q2	8/11/2022	5,351	0.1%	9,052	6/30/2022
2022 Q1	5/9/2022	6,322	0.1%	9,052	3/31/2022
2021 Q4	2/10/2022	5,717	0.1%	9,052	12/31/2021
2021 Q3	11/10/2021	5,478	0.1%	9,052	9/30/2021
2021 Q2	8/6/2021	5,056	0.1%	9,052	6/30/2021
2021 Q1	5/10/2021	4,283	0.1%	9,052	3/31/2021
2020 Q4	2/12/2021	4,373	0.1%	9,052	12/31/2020
2020 Q3	11/10/2020	5,067	0.2%	9,052	9/30/2020
2020 Q2	8/11/2020	5,645	0.2%	9,052	6/30/2020
2020 Q1	5/28/2020	7,435	0.4%	15,226	3/31/2020
2019 Q4	2/10/2020	5,913	0.3%	15,747	12/31/2019